{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T12:06:47Z","timestamp":1784117207930,"version":"3.55.0"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Dejerine\u2013Sottas disease (DSD) is a severe early-onset hereditary demyelinating neuropathy, but its overlap with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) has rarely been described in children. We report a child in whom influenza B-triggered CIDP led to the recognition of a previously undiagnosed PMP22-related hereditary demyelinating neuropathy with a severe Dejerine\u2013Sottas-like phenotype. The patient had longstanding developmental delay and neuropathic features before the acute illness. After severe influenza B infection, he developed progressive weakness lasting more than 8\u202fweeks, marked albuminocytologic dissociation, biphasic cytokine elevation in serum and cerebrospinal fluid (CSF), diffuse peripheral nerve enlargement, and electrophysiological evidence of diffuse, largely symmetric sensorimotor polyneuropathy with prominent demyelinating features and secondary axonal involvement. Genetic testing identified a maternally inherited heterozygous 1.38-Mb deletion at chromosome 17p12 involving the dosage-sensitive PMP22 gene. Treatment with intravenous immunoglobulin and corticosteroids was followed by improvements consciousness, respiratory function, limb strength, and cytokine levels, although motor recovery remained incomplete. In children with features of hereditary neuropathy, acute or subacute deterioration after infection should prompt evaluation for superimposed CIDP, as the inflammatory component may be responsive to immunotherapy.<\/jats:p>","DOI":"10.3389\/fmed.2026.1841187","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:10:19Z","timestamp":1784113819000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Influenza B-triggered CIDP revealing PMP22-related Dejerine\u2013Sottas-like neuropathy in a child\u2014biphasic cytokine dynamics and response to immunotherapy"],"prefix":"10.3389","volume":"13","author":[{"given":"Yazhen","family":"Fan","sequence":"first","affiliation":[{"name":"Department of Pediatric Intensive Care Unit, The Third Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junying","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Pediatric Intensive Care Unit, The Third Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingpo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Intensive Care Unit, The Third Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchuang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pediatric Intensive Care Unit, The Third Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjie","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Intensive Care Unit, The Third Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhang","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Pediatric Intensive Care Unit, The Third Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Intensive Care Unit, The Third Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1093\/hmg\/ddy191","article-title":"Regulation of the neuropathy-associated Pmp22 gene by a distal super-enhancer","volume":"27","author":"Pantera","year":"2018","journal-title":"Hum Mol Genet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1136\/jnnp-2014-309697","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype","volume":"86","author":"Mathey","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000494291","article-title":"Incidence and prevalence of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and Meta-analysis","volume":"52","author":"Broers","year":"2019","journal-title":"Neuroepidemiology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/S1474-4422(19)30144-9","article-title":"Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"18","author":"Bunschoten","year":"2019","journal-title":"Lancet Neurol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"784144","DOI":"10.3389\/fneur.2021.784144","article-title":"Corrigendum: pediatric CIDP: diagnosis and management. A single-center experience","volume":"12","author":"\u0141ukawska","year":"2021","journal-title":"Front Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s12028-020-01123-x","article-title":"Intensive care unit-acquired weakness in children: a prospective observational study using simplified serial electrophysiological testing (PEDCIMP study)","volume":"34","author":"Kasinathan","year":"2021","journal-title":"Neurocrit Care"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1111\/ene.14959","article-title":"European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision","volume":"28","author":"Van den Bergh","year":"2021","journal-title":"Eur J Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41572-018-0027-2","article-title":"Immune-mediated neuropathies","volume":"4","author":"Kieseier","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.1111\/ene.16073","article-title":"European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of Guillain-Barr\u00e9 syndrome","volume":"30","author":"van Doorn","year":"2023","journal-title":"Eur J Neurol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1212\/WNL.0b013e3181e07d14","article-title":"Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study","volume":"74","author":"Ruts","year":"2010","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jocn.2020.03.014","article-title":"Immune-mediated inflammatory polyneuropathy overlapping Charcot-Marie-tooth 1B","volume":"75","author":"Escorcio-Bezerra","year":"2020","journal-title":"J Clin Neurosci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S1474-4422(04)00822-1","article-title":"Immune-mediated components of hereditary demyelinating neuropathies: lessons from animal models and patients","volume":"3","author":"Martini","year":"2004","journal-title":"Lancet Neurol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/jns.12362","article-title":"Sporadic hereditary neuropathies misdiagnosed as chronic inflammatory demyelinating polyradiculoneuropathy: pitfalls and red flags","volume":"25","author":"Campagnolo","year":"2020","journal-title":"J Peripher Nerv Syst"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s10072-020-04789-5","article-title":"CIDP, CMT1B, or CMT1B plus CIDP","volume":"42","author":"Cardellini","year":"2021","journal-title":"Neurol Sci"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.nmd.2020.11.013","article-title":"Genetic neuropathies presenting with CIDP-like features in childhood","volume":"31","author":"Fernandez-Garcia","year":"2021","journal-title":"Neuromuscul Disord"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"14411","DOI":"10.1038\/s41598-017-14853-4","article-title":"Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"7","author":"Querol","year":"2017","journal-title":"Sci Rep"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3389\/fimmu.2018.01029","article-title":"Autoantibodies against the node of Ranvier in seropositive chronic inflammatory demyelinating polyneuropathy: diagnostic, pathogenic, and therapeutic relevance","volume":"9","author":"Vural","year":"2018","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1007\/s13311-021-01117-3","article-title":"Novel immunological and therapeutic insights in Guillain-Barr\u00e9 syndrome and CIDP","volume":"18","author":"Querol","year":"2021","journal-title":"Neurotherapeutics"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1474-4422(17)30378-2","article-title":"Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"17","author":"van Schaik","year":"2018","journal-title":"Lancet Neurol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/jns.12653","article-title":"Long-term and low-dose rituximab treatment for chronic inflammatory demyelinating polyneuropathy","volume":"29","author":"Zheng","year":"2024","journal-title":"J Peripher Nerv Syst"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1841187\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:10:27Z","timestamp":1784113827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1841187\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":20,"alternative-id":["10.3389\/fmed.2026.1841187"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1841187","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"article-number":"1841187"}}